China Medical Association Tuberculosis Society Honors Lilly with Best Partner Award

Primary tabs

China Medical Association Tuberculosis Society Honors Lilly with Best Partner Award

tweet me:
.@LillyPad is honored with the awards in #China for the MDR-TB Partnership and efforts against #TB. http://cot.ag/18U9WCy

Multimedia from this Release

Awarding ceremony

Dr. Evan Lee

Friday, August 2, 2013 - 10:15am

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

Guest blog from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.

The Eli Lilly and Company Foundation was honored to receive the Best Partner Award at the China Medical Association Tuberculosis (CMA TB) Society 2013 Annual Academic Congress, which took place in Chongqing, China on July 18-20. This is very special recognition, as it is the first time the CMA TB Society has granted these awards to companies and institutional partners for their efforts against TB.

Lilly has been deeply committed to the global fight against MDR-TB for more than a decade. Since its launch in 2003 we have made significant investments of over $150 million in combined value through funding, donated product, and volunteer expertise via the Lilly MDR-TB Partnership. We are continuing our commitment through 2016, with an additional funding of $30 million and continued sharing of our expertise, to focus on strengthening the capacity of healthcare professionals to detect and manage MDR-TB, and to improve access to safe, effective and quality-assured second-line TB drugs.

Read more about Lilly's collaboration with CMA TB Society

Keywords: Social Impact & Volunteering | China Medical Association | Eli Lilly and Company | Health & Healthcare | Lilly MDR-TB Partnership | tb | tuberculosis

CAMPAIGN: Lilly Global Health Programs

CONTENT: Blog

parse.ly